ESTRO35 Programme Book

MONDAY 2 MAY 2016

> Changes of the density CD8+ tumour infiltrating lymphocytes after neoadjuvant radiochemotherapy D. Buka (Czech Republic), J. Dvorak, V. Sitorova, I. Richter, I. Sirak > Mechanisms and abscopal effects of combined mRNA-based radioim- munotherapy in a syngenic mouse model. L. Basler (Germany), A. Kowalczyk, M. Fotin-Mleczek, K.J. Kallen, D. Zips, S.M. Huber Symposium MODERN ART BASED ON FUNCTIONAL / BIOLOGICAL IMAGING 10:45 - 11:45 | ROOM 2 This session covers functional imaging for adaptive radiotherapy, with a focus on head and neck cancer. FDG, hypoxia tracers such as F-MISO and FAZA and tracers for proliferation imaging are interesting PET tracers that may be used in adaptive radiotherapy and for patient selection in targeted therapy. How can these imaging modalities be incorporated in an adaptive workflow and what is the rol/ responsibility of the RTT in this process? As example the ARTFORCE trial is described, with a discus- sion on the use of dose accumulation for assessment of local dose. Future perspectives on imaging and adaptive replanning will be addressed. Chair: U. Van der Heide (The Netherlands) Co-chair: F. Alongi (Italy) 10:45 > Functional imaging for ART; biological bases and potential impact on clinical outcome Speaker: B. Hoeben (The Netherlands) 11:05 > Adaptive radiation therapy by the example of head and neck cancer: is there any role for a RTT? Speaker: B. Speleers (Belgium) 11:25 > Dosimetric impact of dose painting and replanning: ARTFORCE project Speaker: J. Sonke (The Netherlands)

PV-0431

PV-0432

SP-0433

SP-0434

SP-0435

Symposium SECONDARY CANCER AFTER RADIOTHERAPY: FROMCANCER REGISTRIES TO CLINICAL IMPLICATIONS 10:45 - 11:45 | ROOM 4

Chair: L.P. Muren (Denmark) Co-chair: A.R. Filippi (Italy)

10:45 > Radiotherapy-related second cancer risks from epidemiological studies, and their application to newer therapies Speaker: A. Berrington de González (USA)

SP-0436

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

127